Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02560636
Title Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer (PLUMMB)
Acronym PLUMMB
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.